Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Intel reported for Q2 2023

7/28/23 INTC

Double growth of Globaltruck shares does not have objective reasons

7/28/23 GTRK

Rusal reported for 6 months of 2023 by RAS

7/28/23 RUAL

The Alcoa announced a quarterly dividend

7/27/23 AA

Alrosa's joint venture in Zimbabwe will complete exploration by the end of the year

7/27/23 ALRS

EL5-Energo in the first half of the year reduced energy generation by 2.6%

7/27/23 ELFV

TotalEnergies will buy gas from Arctic LNG-2

7/27/23 NVTK

The Comcast announced a quarterly dividend

7/27/23 CMCSA

Pyaterochka was deprived of its license to sell alcohol in St. Petersburg

7/27/23 FIVE

VTB launched a pilot to reach out to the mass client segment

7/27/23 VTBR